A study published in @jeadv_ explored the effectiveness and safety of dutasteride intralesional microinjections (DIM) in combination with oral minoxidil compared with oral minoxidil monotherapy in men with androgenetic alopecia. In this retrospective single-center study, male patients were treated with oral minoxidil 1-5 mg daily alone or in combination with DIM. Observed side effects were related to oral minoxidil in both groups, and no sexual dysfunction was reported in any participant. . Combination therapy of oral minoxidil with the intralesional dutasteride led to significantly greater improvement at the vertex compared with the outcomes of the oral minoxidil monotherapy. While more research is needed, the authors said that treatment efficacy and relief from risk of sexual dysfunction may provide an alternative therapeutic option for men. . Visit the link in our bio to learn more in #DermWorldWeekly.